Food and Drug Administration health advisors voted Thursday in favor of expanding public access to a peptide chemical that Health and Human Services Secretary Robert F. Kennedy Jr. has promoted.
The panel of advisors voted 8-6 to recommend broadening BPC-157, a popular peptide. They are expected to vote on six other peptides Friday.